1. Ji, Jing, Shen, Jing, Xu, Yuxin, Liu, Wei, Liu, Bin. 2022. FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development. In Cell death & disease, 13, 442. doi:10.1038/s41419-022-04892-9. https://pubmed.ncbi.nlm.nih.gov/35525855/
2. Zhao, Xunming, Guo, Weichun, Zou, Lixue, Hu, Biao. 2020. FBXO2 modulates STAT3 signaling to regulate proliferation and tumorigenicity of osteosarcoma cells. In Cancer cell international, 20, 245. doi:10.1186/s12935-020-01326-4. https://pubmed.ncbi.nlm.nih.gov/32549792/
3. Guo, Wenke, Ren, Yaoqiang, Qiu, Xinguang. 2024. FBXO2 promotes the progression of papillary thyroid carcinoma through the p53 pathway. In Scientific reports, 14, 22574. doi:10.1038/s41598-024-73455-z. https://pubmed.ncbi.nlm.nih.gov/39343799/
4. Cherif, Hosni, Mannarino, Matthew, Pacis, Alain Sarabia, Ouellet, Jean A, Haglund, Lisbet. 2022. Single-Cell RNA-Seq Analysis of Cells from Degenerating and Non-Degenerating Intervertebral Discs from the Same Individual Reveals New Biomarkers for Intervertebral Disc Degeneration. In International journal of molecular sciences, 23, . doi:10.3390/ijms23073993. https://pubmed.ncbi.nlm.nih.gov/35409356/
5. Hartman, Byron H, Bӧscke, Robert, Ellwanger, Daniel C, Scheibinger, Mirko, Heller, Stefan. 2018. Fbxo2VHC mouse and embryonic stem cell reporter lines delineate in vitro-generated inner ear sensory epithelia cells and enable otic lineage selection and Cre-recombination. In Developmental biology, 443, 64-77. doi:10.1016/j.ydbio.2018.08.013. https://pubmed.ncbi.nlm.nih.gov/30179592/
6. Liu, Zhi, Chen, Ning-Yuan, Zhang, Zhao, Zhou, Sai, Hu, San-Yuan. . F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit. In World journal of gastroenterology, 29, 4433-4450. doi:10.3748/wjg.v29.i28.4433. https://pubmed.ncbi.nlm.nih.gov/37576703/
7. Cheng, Jingyi, Liu, Ousheng, Bin, Xin, Tang, Zhangui. 2024. FBXO2 as a switch guides a special fate of tumor clones evolving into a highly malignant transcriptional subtype in oral squamous cell carcinoma. In Apoptosis : an international journal on programmed cell death, 30, 167-184. doi:10.1007/s10495-024-02033-5. https://pubmed.ncbi.nlm.nih.gov/39487312/
8. Williams, Jamal B, Cao, Qing, Wang, Wei, Ma, Kaijie, Yan, Zhen. 2023. Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model. In Nature communications, 14, 91. doi:10.1038/s41467-022-35749-6. https://pubmed.ncbi.nlm.nih.gov/36609445/
9. Atkin, Graham, Moore, Shannon, Lu, Yuan, Murphy, Geoffrey G, Paulson, Henry. . Loss of F-box only protein 2 (Fbxo2) disrupts levels and localization of select NMDA receptor subunits, and promotes aberrant synaptic connectivity. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 35, 6165-78. doi:10.1523/JNEUROSCI.3013-14.2015. https://pubmed.ncbi.nlm.nih.gov/25878288/
10. Yuan, Lamei, Song, Zhi, Deng, Xiong, Lu, Hongwei, Deng, Hao. 2017. Genetic Analysis of FBXO2, FBXO6, FBXO12, and FBXO41 Variants in Han Chinese Patients with Sporadic Parkinson's Disease. In Neuroscience bulletin, 33, 510-514. doi:10.1007/s12264-017-0122-5. https://pubmed.ncbi.nlm.nih.gov/28341977/